Related references
Note: Only part of the references are listed.Regulation of Hippo signaling and triple negative breast cancer progression by an ubiquitin ligase RNF187
Zhonghao Wang et al.
ONCOGENESIS (2020)
Phosphorylation Control of p53 DNA-Binding Cooperativity Balances Tumorigenesis and Aging
Oleg Timofeev et al.
CANCER RESEARCH (2020)
The ubiquitin ligase RNF181 stabilizes ERα and modulates breast cancer progression
Jian Zhu et al.
ONCOGENE (2020)
TP53 Mutations and Outcomes in Breast Cancer: Reading beyond the Headlines
Ashkan Shahbandi et al.
TRENDS IN CANCER (2020)
Progress in adjuvant systemic therapy for breast cancer
Noam F. Ponde et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
RBCK1 promotes p53 degradation via ubiquitination in renal cell carcinoma
Sifan Yu et al.
CELL DEATH & DISEASE (2019)
Regulation of estrogen signaling and breast cancer proliferation by an ubiquitin ligase TRIM56
Min Xue et al.
ONCOGENESIS (2019)
Awakening the guardian of genome: reactivation of mutant p53
Akshay Binayke et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2019)
SHARPIN Facilitates p53 Degradation in Breast Cancer Cells
Huijie Yang et al.
NEOPLASIA (2017)
RING finger protein 31 promotes p53 degradation in breast cancer cells
J. Zhu et al.
ONCOGENE (2016)
Significance of TP53 mutations determined by next-generation deep sequencing in prognosis of estrogen receptor-positive breast cancer
Kumiko Uji et al.
CANCER LETTERS (2014)
Knockdown of RNF2 induces apoptosis by regulating MDM2 and p53 stability
W. Wen et al.
ONCOGENE (2014)
Mutant p53 Prolongs NF-κB Activation and Promotes Chronic Inflammation and Inflammation-Associated Colorectal Cancer
Tomer Cooks et al.
CANCER CELL (2013)
p53-Mediated Senescence Impairs the Apoptotic Response to Chemotherapy and Clinical Outcome in Breast Cancer
James G. Jackson et al.
CANCER CELL (2012)
Viral oncoprotein LMP1 disrupts p53-induced cell cycle arrest and apoptosis through modulating K63-linked ubiquitination of p53
Lili Li et al.
CELL CYCLE (2012)
Smad Ubiquitylation Regulatory Factor 1/2 (Smurf1/2) Promotes p53 Degradation by Stabilizing the E3 Ligase MDM2
Jing Nie et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Identification of a co-activator that links growth factor signalling to c-Jun/AP-1 activation
Clare C. Davies et al.
NATURE CELL BIOLOGY (2010)
Transcriptional Regulation of Estrogen Receptor-α by p53 in Human Breast Cancer Cells
Stephanie Harkey Shirley et al.
CANCER RESEARCH (2009)
Analysis of p53 mutation status in human cancer cell lines - A paradigm for cell line cross-contamination
Hanna Berglind et al.
CANCER BIOLOGY & THERAPY (2008)
P-53 gene mutations as a predictive marker in a population of advanced breast cancer patients randomly treated with doxorubicin or docetaxel in the context of a phase III clinical trial
A. Di Leo et al.
ANNALS OF ONCOLOGY (2007)
Are interactions with p63 and p73 involved in mutant p53 gain of oncogenic function?
Y. Li et al.
ONCOGENE (2007)
Exquisite sensitivity of TP53 mutant and basal breast cancers to a dose-dense epirubicin-cyclophosphamide regimen
Philippe Bertheau et al.
PLOS MEDICINE (2007)
Structural basis of DNA recognition by p53 tetramers
Malka Kitayner et al.
MOLECULAR CELL (2006)
An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival
LD Miller et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The chaperone-associated ubiquitin ligase CHIP is able to target p53 for proteasomal degradation
C Esser et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The ubiquitin ligase COP1 is a critical negative regulator of p53
D Dornan et al.
NATURE (2004)
p53 binds to cisplatin-damaged DNA
CC Wetzel et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION (2001)
p53 from complexity to simplicity: mutant p53 stabilization, gain-of-function, and dominant-negative effect
MV Blagosklonny
FASEB JOURNAL (2000)
Tissue and cell-specific expression of the p53-target genes: bax, fas, mdm2 and waf1/p21, before and following ionising irradiation in mice
V Bouvard et al.
ONCOGENE (2000)
Share Paper
